FDA Inspection 1172929 — Panacea Biotec Pharma Limited

Panacea Biotec Pharma Limited — FEI 3007187282

The FDA completed an inspection of Panacea Biotec Pharma Limited on Jun 8, 2022 in Malpur. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jun 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malpur (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.